🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the pathophysiology of recurrent pericarditi...
Status
Unknown
Location
Saarland University
Start Date
2023-07-01
Trial ID
NCT05925790
Treatments Being Tested
This is a retrospective, non interventional cohort study using stored plasm...
Status
Completed
Location
Michigan state university, Department of Biostatistics
Start Date
2020-02-01
Trial ID
NCT07466524
Treatments Being Tested
The goal of this observational study is to learn about the role of biomarke...
Status
Unknown
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-01-15
Trial ID
NCT06218654
Treatments Being Tested
The purpose of this study is to determine whether the improved responsivene...
Status
Unknown
Location
Nephrology Dept.,Guangdong General Hospital
Start Date
2011-01
Trial ID
NCT01468493
This study investigates the association between level of suPAR and valvular...
Status
Completed
Location
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
Start Date
2020-08-14
Trial ID
NCT04571372
The biomarker soluble urokinase plasminogen activator receptor (suPAR) is t...
Status
Completed
Location
University Hospital of Larisa, Department of Anesthesiology
Start Date
2020-10-11
Trial ID
NCT04590794
Treatments Being Tested
Introduction: To evaluate the maternal blood serum melatonin, soluble uroki...
Status
Unknown
Location
Cengiz Gokcek Women's and Children's Hospital
Start Date
2020-10-07
Trial ID
NCT04588220
Treatments Being Tested
The purpose of the study is to determine whether plasma levels of the solub...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04105439
The aim of this clinical study is; Comparatively comparing salivary Soluble...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06430450
Treatments Being Tested
In critically ill patients, the soluble urokinase plasminogen activator rec...
Status
Completed
Location
University Hospital of Larisa, Department of Anesthesiology
Start Date
2019-04-15
Trial ID
NCT03851965
Treatments Being Tested